An interventional study of Stair climbing in Hypertension and Menopause, sponsored by Pusan National University. Completed. Open to female participants aged 58 Years to 60 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2020-11-03.
Sponsored by Pusan National University · Not applicable, Interventional, and Health services research
We used a parallel experimental design. Following an initial screening and familiarization session of study tests and procedures, eligible postmenopausal women were randomly assigned to a stair climbing (SC) group or non-exercising control group. SC training session was progressive program, and was performed 4 days a week for 12 weeks. Measurements were collected at baseline and after 12 weeks during the same time of day (±1 hour) in the morning following an overnight fast and abstinence from caffeinated drinks, alcohol, and between 48 and 72 hours after the last exercise session.
Exclusion Criteria:
N=20, 12 weeks of stair climbing exercise training.
Behavioral: Stair climbing
N=21, No exercise for 12 weeks
Stair climbing (SC) training was 12 weeks of progressive SC program. Each training session consisted of a general warm-up (5 min: slow and fast skipping, stretching) followed by the SC training and was supervised by experienced personnel. The program began with two bouts of stair climbing four days a week in weeks 1 and 2, increasing by one climb a day every three weeks. By the last three weeks (10-12) of the study, all subjects were completing 5 climbs four days a week. During each climb participants ascended 12 flights (192 steps) divided into 3 sets of 4 flights, with a 2 min rest period between each set. There was a 5 min rest period between climbs that allowed the participants to reach the ground floor using an elevator. Subjects in the non-exercising control group did not participate in a supervised exercise program for the duration of the study.
Arterial stiffness
Arterial stiff ness was measured by brachial to ankle pulse wave velocity (baPWV, m/s) using volume plethysmographic device (VP-1000).
Time frame: 12 weeks
Blood pressure (BP)
BP (mmHg) was measured by volume plethysmographic device. Diastolic blood pressure and systolic blood pressure were measured.
Time frame: 12 weeks
Muscle strength
Muscle strength was measured by the eight repetition maximum (8RM) test using extension machine (Cyber 6000).
Time frame: 12 weeks
Body composition
Body composition was measured using eight-polar tactile-electrode impedance meter (InBody 720). Body weight (kg), fat mass (kg), and fat free mass (kg) were assessed.
Time frame: 12 weeks
Height
Height (m) was measured with a stadiometer
Time frame: 12 weeks
Heart rate (HR)
Heart rate was measured by ECG
Time frame: 12 weeks
Body mass index (BMI)
BMI was calculated as weight/height\^2 (kg/m\^2)
Time frame: 12 weeks
No study locations are listed for this record.
This study is completed, as verified in Oct 2020. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Pusan National University